Lataa...
Adolescent Asthma Pharmacotherapy in a State of Flux
Recently, the United States Food and Drug Administration (FDA) elected not to approve a once-daily inhaled corticosteroid/long-acting β2 agonist combination product in 12–17-year-old patients due to lack of sufficient data, despite approval of previous combination products with similar levels of sup...
Tallennettuna:
| Julkaisussa: | Pediatr Allergy Immunol Pulmonol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Mary Ann Liebert, Inc.
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4580303/ https://ncbi.nlm.nih.gov/pubmed/26421215 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/ped.2015.0562 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|